$27.00
-10.19 (-27.40%)
Open$35.34
Previous Close$37.19
Day High$35.45
Day Low$27.00
52W High$209.03
52W Low$2.29
Volume—
Avg Volume5.99M
Market Cap19.87M
P/E Ratio—
EPS$-294.14
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 41.56M | 777.7K | 707.3K |
| Net Income | -203,443,513 | 128.9K | 94.3K |
| Profit Margin | -489.6% | 16.6% | 13.3% |
| EBITDA | -144,074,817 | 197.3K | 212.4K |
| Free Cash Flow | — | 80.3K | 76.9K |
| Rev Growth | +172.4% | -2.7% | +7.8% |
| Debt/Equity | 0.08 | 0.46 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |